Holen Sie sich die Stockscreener-App
5.06
28.10%
1.11
Handel nachbörslich:
5.12
0.06
+1.19%
Aquestive Therapeutics Inc Aktie (AQST) Neueste Nachrichten
Aquestive gains as allergy therapy undergoes FDA review - MSN
Why Is Aquestive Therapeutics Stock Soaring Thursday?Aquestive Therapeutics (NASDAQ:AQST) - Benzinga
Aquestive Therapeutics Shares Rise, FDA Forgos Meeting on Anaphylm - MarketScreener
Aquestive Therapeutics shares surge 21.39% intraday after FDA waives advisory committee meeting for Anaphylm, a device-free, sublingual epinephrine film for severe allergic reactions. - AInvest
Analyzing recovery setups for Aquestive Therapeutics Inc. investorsJuly 2025 WrapUp & Verified Chart Pattern Trade Signals - Newser
Aquestive Therapeutics, Inc. Announces FDA Will Not Require an Advisory Committee Meeting to Discuss New Drug Application for Anaphylm?? - MarketScreener
Aquestive Therapeutics Shares Soar 20% on FDA Approval Pathway - AInvest
Aquestive says no FDA AdCom for Anaphylm (AQST:NASDAQ) - Seeking Alpha
Aquestive climbs after US FDA says no advisory panel needed for epinephrine film - TradingView
FDA won’t require advisory committee meeting for Aquestive’s anaphylaxis film - Investing.com
Aquestive Therapeutics Announces that FDA Will Not Require - GlobeNewswire
First-Ever Needle-Free Epinephrine Film: Aquestive's Anaphylm Clears Key FDA Hurdle Without Committee Review - Stock Titan
Will Aquestive Therapeutics Inc. stock recover after recent dropMarket Growth Summary & Risk Managed Trade Strategies - Newser
Measuring Aquestive Therapeutics Inc.’s beta against major indicesEarnings Beat & Stepwise Trade Signal Implementation - Newser
Published on: 2025-09-03 22:42:37 - Newser
Aquestive Therapeutics Inc. stock retracement – recovery analysisInflation Watch & Real-Time Price Movement Reports - Newser
Can Aquestive Therapeutics Inc. ride the EV waveSell Signal & Intraday High Probability Alerts - khodrobank.com
News impact scoring models applied to Aquestive Therapeutics Inc.Market Performance Report & Fast Moving Stock Watchlists - Newser
What momentum shifts mean for Aquestive Therapeutics Inc.Weekly Trend Summary & Safe Capital Growth Plans - Newser
Risk adjusted return profile for Aquestive Therapeutics Inc. analyzed2025 Breakouts & Breakdowns & Safe Capital Allocation Plans - Newser
Live market analysis of Aquestive Therapeutics Inc.Gold Moves & Accurate Intraday Trade Tips - Newser
Is Aquestive Therapeutics Inc. forming a reversal patternM&A Rumor & Short-Term High Return Strategies - Newser
Aquestive Therapeutics Inc. stock prediction for this week2025 Historical Comparison & Accurate Intraday Trade Tips - Newser
Regression analysis insights on Aquestive Therapeutics Inc. performanceWeekly Loss Report & Verified Momentum Watchlists - Newser
Momentum divergence signals in Aquestive Therapeutics Inc. chart - Newser
How moving averages guide Aquestive Therapeutics Inc. tradingJuly 2025 Trade Ideas & Capital Efficient Trading Techniques - Newser
Can Aquestive Therapeutics Inc. continue delivering strong returns2025 Big Picture & AI Powered Market Entry Ideas - khodrobank.com
Is Aquestive Therapeutics Inc. stock entering bullish territoryJuly 2025 Outlook & AI Optimized Trade Strategies - Newser
Aquestive Therapeutics Inc. recovery potential after sell offPortfolio Gains Report & Risk Managed Investment Strategies - Newser
Can Aquestive Therapeutics Inc. hit a new high this monthEarnings Growth Report & Safe Capital Growth Tips - Newser
Comparing Aquestive Therapeutics Inc. in custom built stock radarsJuly 2025 Big Picture & Low Drawdown Investment Ideas - Newser
What Fibonacci levels say about Aquestive Therapeutics Inc. reboundJuly 2025 Gainers & Pattern Based Trade Signal System - Newser
Aquestive Therapeutics Inc. stock daily chart insightsJuly 2025 Reactions & Free Safe Capital Growth Stock Tips - Newser
Published on: 2025-09-02 04:19:41 - Newser
What are Aquestive Therapeutics Inc.’s recent SEC filings showing2025 Investor Takeaways & Low Drawdown Momentum Trade Ideas - khodrobank.com
Evaluating Aquestive Therapeutics Inc. with trendline analysis2025 Performance Recap & Technical Pattern Alert System - Newser
What’s the profit margin of Aquestive Therapeutics Inc.Market Performance Summary & Weekly High Return Opportunities - khodrobank.com
Using portfolio simulators with Aquestive Therapeutics Inc. includedWeekly Gains Summary & AI Forecast for Swing Trade Picks - Newser
Aquestive Therapeutics’ SWOT analysis: needle-less epinephrine stock poised for growth - Investing.com
Technical analysis overview for Aquestive Therapeutics Inc. stockJuly 2025 Decliners & Momentum Based Trading Signals - Newser
Aquestive Therapeutics’ Earnings Call: Progress Amid Challenges - TipRanks
Applying Wyckoff theory to Aquestive Therapeutics Inc. stockQuarterly Portfolio Report & Smart Investment Allocation Insights - Newser
Technical signs of recovery in Aquestive Therapeutics Inc.July 2025 Short Interest & AI Powered Buy/Sell Recommendations - Newser
Order flow analysis tools used on Aquestive Therapeutics Inc.Treasury Yields & Safe Capital Growth Tips - Newser
3.60%
0.69%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):